PedAM
Pediatric Disease Annotations & Medicines
| Disease | myocardial infarction |
| Phenotype | C0155616|secondary hypertension |
| Sentences | 3 |
| PubMedID- 24457614 | Exclusion criteria for the study were secondary hypertension; a history of myocardial infarction, coronary revascularization, heart failure, or stroke; cardiovascular disease; valvular heart disease; atrial fibrillation and severe arrhythmia; overt infection (as assessed by crp ≥ 1.0 mg/dl) or active inflammatory disease; and malignant disease. |
| PubMedID- 24384734 | Patients were excluded from this study if they had severe hypertension (sisbp ≥180 mm hg), secondary hypertension, a history of myocardial infarction or unstable angina pectoris, congestive heart failure, anemia (hemoglobin <10.0 g/dl), renal disease (serum creatinine concentration >1.4 mg/dl), coagulopathy, peripheral arterial disease, hepatic disease (aspartate aminotransferase [ast] or alanine aminotransferase [alt] >2.5-fold the upper limit of normal), uncontrolled diabetes (glycosylated hemoglobin [hba1c] >8.0%), a history of metabolic acidosis or diabetic ketoacidosis, cancer, known hypersensitivity to ccbs, alcoholism, or other drug addiction. |
| PubMedID- 22529996 | Patients who had renal failure, significant hepatic disease, secondary hypertension, a history of myocardial infarction, significant coronary artery disease (cad; coronary artery stenosis ≥70%), pericardial disease, significant valvular heart disease (≥moderate), chronic obstructive pulmonary disease, or chronic atrial fibrillation were excluded. |
Page: 1